Holen Sie sich die Stockscreener-App
1.95
22.64%
0.36
Schlusskurs vom Vortag:
$1.59
Offen:
$1.58
24-Stunden-Volumen:
626.37K
Relative Volume:
1.22
Marktkapitalisierung:
$51.92M
Einnahmen:
$521.00K
Nettoeinkommen (Verlust:
$-8.53M
KGV:
-0.7569
EPS:
-2.5762
Netto-Cashflow:
$-7.71M
1W Leistung:
+44.44%
1M Leistung:
+40.29%
6M Leistung:
-68.03%
1J Leistung:
-24.54%
1-Tages-Spanne:
$1.57
$1.98
1-Wochen-Bereich:
$1.37
$1.98
52-Wochen-Spanne:
$1.11
$99.75
Novabay Pharmaceuticals Inc Stock (NBY) Company Profile
Firmenname
Novabay Pharmaceuticals Inc
Sektor
Branche
Telefon
510-899-8800
Adresse
2000 Powell Street, Suite 1150, Emeryville, CA
Compare NBY vs VRTX, REGN, ARGX, ALNY, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NBY
Novabay Pharmaceuticals Inc
|
1.95 | 51.92M | 521.00K | -8.53M | -7.71M | -2.5762 |
VRTX
Vertex Pharmaceuticals Inc
|
435.29 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
759.26 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
747.15 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
330.52 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
164.06 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Novabay Pharmaceuticals Inc Stock (NBY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2019-09-18 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2018-07-06 | Bestätigt | H.C. Wainwright | Buy |
| 2017-11-15 | Bestätigt | Laidlaw | Buy |
| 2017-06-05 | Eingeleitet | ROTH Capital | Buy |
| 2017-03-27 | Eingeleitet | Laidlaw | Buy |
| 2017-02-06 | Eingeleitet | Rodman & Renshaw | Buy |
| 2016-03-07 | Herabstufung | Maxim Group | Buy → Hold |
| 2015-12-14 | Bestätigt | Maxim Group | Buy |
| 2015-04-30 | Fortgesetzt | Maxim Group | Buy |
| 2013-03-06 | Eingeleitet | Ascendiant Capital Markets | Strong Buy |
| 2008-01-03 | Eingeleitet | Dawson James | Speculative Buy |
Alle ansehen
Novabay Pharmaceuticals Inc Aktie (NBY) Neueste Nachrichten
Stablecoin Development Corporation (SDEV) Focuses on Long-Term Growth in Digital Asset Ecosystems and Sky Protocol Staking 14 - Minichart
Three new option listings and three option delistings on April 6th - TipRanks
Stablecoin Development Corp (NYSE: SDEV) pivots to SKY-focused digital asset strategy - Stock Titan
Stablecoin Development Corporation Begins Trading on NYSE American Under Ticker 'SDEV” - The Manila Times
Big Picture: Does NovaBay Pharmaceuticals Inc offer margin of safetyQuarterly Earnings Report & Reliable Intraday Trade Plans - baoquankhu1.vn
Stablecoin Development Corp: A $134M Bet on SKY Staking Yields - Bitget
Kazley reports 58.1% control stake in Stablecoin Development (NBY) via RSUs - Stock Titan
NovaBay Pharmaceuticals, Inc. will Change its Name to Stablecoin Development Corporation - marketscreener.com
Stablecoin Development (NBY) director awarded 140,000 restricted stock units - Stock Titan
NovaBay Pharmaceuticals Changes Name to Stablecoin Development Corporation and Updates Bylaws and Executive Agreements - Minichart
Stablecoin Development Corp to change name and grants executive equity awards - Investing.com Australia
NovaBay Pharma Rebrands as Stablecoin Development Corporation - TipRanks
NovaBay Pharmaceuticals extends employment of Michael Kazley and Tommy Law with equity awards - TradingView
NovaBay (NBY) grants major RSU awards and renames to Stablecoin Development Corp (SDEV) - Stock Titan
Volatility Watch: Is NovaBay Pharmaceuticals Inc stock heavily shorted2026 Analyst Calls & Long-Term Growth Stock Strategies - baoquankhu1.vn
Aug Big Picture: Can NovaBay Pharmaceuticals Inc sustain its profitabilityPortfolio Risk Report & Fast Gain Stock Tips - baoquankhu1.vn
NovaBay Pharmaceuticals Announces Corporate Name Change to Stablecoin Development Corporation - VisionMonday.com
NBY Should I Buy - Intellectia AI
NovaBay Pharmaceuticals (STU:B9P1) Shiller PE Ratio : (As of Mar. 27, 2026) - GuruFocus
Bull Bear: Is NovaBay Pharmaceuticals Inc stock a top performer YTD2026 Growth vs Value & Accurate Intraday Trade Tips - baoquankhu1.vn
NovaBay rebrands to Stablecoin Development Corp in full crypto pivot—pharma company's stock climbs 19% - MSN
Best Crypto to Buy Now: Pepeto Presale Is Accelerating as NovaBay Rebrands for Crypto While LINK and SOL Hold - MEXC
Aug Macro: Can NovaBay Pharmaceuticals Inc beat the S P 5002026 Analyst Calls & Fast Exit Strategy with Risk Control - baoquankhu1.vn
NovaBay Rebrands To Stablecoin Development Corp In Full Crypto Pivot— Pharma Company's Stock Climbs 19% - Sahm
NovaBay Pharmaceuticals (NBY) Soars 19% Following Stablecoin Transformation Announcement - MEXC Exchange
NovaBay Pharmaceuticals (NBY) Stock Jumps 19% on Stablecoin Pivot - MEXC
Eyecare biotech jumps 19% after stablecoin-focused pivot - TradingView
NovaBay Pharmaceuticals Pivots to Stablecoins in Rebrand - Yahoo Finance
Pharmaceutical Stock Jumps 26% on Crypto Pivot Plan - blockonomi.com
Biotech stock NovaBay jumps 19% amid pivot, rebrand to Stablecoin Development Corporation - The Block
Pharmaceutical stock surges 26% after crypto pivot - thestreet.com
NovaBay Pharmaceuticals to rebrand as Stablecoin Development Corporation - MSN
NovaBay Rebrands as 'Stablecoin Development Corporation' With Nearly 9% of SKY Supply - thedefiant.io
Stablecoin Development Corp (SDEV): Former NovaBay Completes $147M SKY Token Acquisition and Corporate Rebrand - Blockonomi
NovaBay Pharmaceuticals to Rebrand as Stablecoin Development Corporation, Announces SKY Token Holdings and NYSE Ticker Change to SDEV 121314181920 - Minichart
NovaBay Pharmaceuticals shares are trading hi... - Benzinga
U.S. pharmaceutical company drops drugs to invest in crypto - Traders Union
NovaBay Pharma Becomes SDEV, Bets $134M on Sky Protocol Token - Whalesbook
NovaBay Pharmaceuticals (NBY) Stock: Rebrands as Stablecoin Development Corp, Acquires $147M in SKY Tokens - CoinCentral
NovaBay Pharmaceutical (NBY) pivoting to crypto - CoinDesk
NovaBay Rebrands To Stablecoin Development Corp, Shares Jump 12 Percent - Yahoo Finance
NovaBay Pharmaceuticals Announces Name Change to Stablecoin Development Corporation, Reports Initial Staking Rewards, and Provides SKY Token Holdings Update - Bitget
NovaBay (NYSE: NBY) pivots to Stablecoin Development Corp and SDEV ticker - Stock Titan
NovaBay Pharmaceuticals Announces Name Change to Stablecoin Development Corporation, Reports ... - Bluefield Daily Telegraph
If You Invested $1,000 in Novabay Pharma (NBY) - Stock Titan
CEO Moves: Is NovaBay Pharmaceuticals Inc part of any major index2026 Sector Review & Fast Momentum Stock Entry Tips - baoquankhu1.vn
NBY Stock Price, Quote & Chart | NOVABAY PHARMACEUTICALS INC (NYSEARCA:NBY) - ChartMill
NovaBay Pharmaceuticals, Inc. 2025 Annual Report: Financials, Stock Warrants, Preferred Stock, and Corporate Actions - Minichart
NovaBay Pharmaceuticals 10-K: $0.6M Revenue, $(3.80) EPS, heavy net loss - TradingView
NovaBay (NYSE: NBY) pivots from pharma to SKY token and digital assets - Stock Titan
Taxes of NovaBay Pharmaceuticals, Inc. – FWB:B9P1 - TradingView
Finanzdaten der Novabay Pharmaceuticals Inc-Aktie (NBY)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.90%
1.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):